The success of a clinical study depends on the CRO’s or sponsor’s ability to bring together people, processes, and technology in a coordinated effort to improve patient outcomes, one case at a time.
To help you understand why personalized therapies require a personalized supply chain, we’ve published Tomorrow’s Medicine: Curing One Patient at a Time – an e-book highlighting the logistics challenges of cell and gene therapies.
Top 10 questions and answers to consider when conducting direct to patient clinical trials
Japan is the world's second largest single-country pharmaceutical market, accounting for approximately 10 per cent of global drug sales, and is expanding very quickly.
Scandinavia and Nordic progression with clinical trials
After a 6,250 mile journey from Bolivia to Scotland, the samples from the APEX 4 expedition are being analyzed by the University of Edinburgh...
.jpg?h=56&iar=0&w=56&useCustomFunctions=1¢erCrop=1&hash=5C3BF081DEFE0CD4643E0D660948B3B2)
